Search results
May 28, 2024 · September 1246 als Mitregent seines Vaters, April 1249 als Fürst; Heirat: vor 1248 mit Euphemia von Pommerellen; war 1249 - 1260 regierender Fürst von Rügen; bei einem von Jaromar brutal geführten Feldzug während innerdänischer Auseinandersetzungen wird er auf Seeland durch eine rächende Frau mit dem Dolch getötet;
- Bergen auf Rügen
- circa 1218
- "Yaromar II", "Vizlavsson"
- Bergen auf Rügen, Pommern, Prussia
Jun 6, 2024 · Level III and Level III+ plate carriers are designed for extended wear, but the added weight of Level III+ can make a noticeable difference as the hours add up. If your role requires long periods of wear, consider the ergonomics of the armor—look for features like padded straps, moisture-wicking fabrics, and breathable materials that help ...
Jun 5, 2024 · LBA4002 Background: In pts with HER2-negative advanced gastric/GEJ cancer and PD-L1 low/absent expression, platinum/fluoropyrimidine doublets are a standard first-line therapy. In this patient population, the outcomes are unsatisfactory and second-line therapy is given in only 40% of clinical trial patients. Switch consolidation maintenance may prolong the benefit of the initial strategy and ...
6 days ago · We randomly assigned 870 patients with resected stage III melanoma with BRAF V600 mutations to receive 12 months of dabrafenib (150 mg twice daily) plus trametinib (2 mg once daily) or two matched ...
Jun 12, 2024 · Take down gigantic monsters, bring your smarts to the pitch or the medieval world, explore a surrealistic post-human world, and much more with June’s PlayStation Plus Game Catalog lineup! Monster Hunter Rise, Football Manager 2024, Crusader Kings III, After Us, and many more games will be available from June 18.
Jun 2, 2024 · Dummer R, Hauschild A, Santinami M, et al. Five-year analysis of adjuvant dabrafenib plus trametinib in stage III melanoma. N Engl J Med. 2020;383(12):1139-1148. Patel SP, Othus M, Chen Y, et al. Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N Engl J Med. 2023;388(9):813-823.
Jun 18, 2024 · PURPOSE AMEERA-5 investigated amcenestrant (oral selective estrogen receptor [ER] degrader) plus palbociclib versus letrozole plus palbociclib as first-line treatment for ER-positive/human epidermal growth factor receptor 2–negative (ER+/HER2–) advanced/metastatic breast cancer (aBC). MATERIALS AND METHODS In AMEERA-5 (ClinicalTrials.gov identifier: NCT04478266), a double-blind, double ...
